Log In
Print
BCIQ
Print
Print this Print this
 

HDAC1/2 inhibitor

  Manage Alerts
Collapse Summary General Information
Company Acetylon Pharmaceuticals Inc.
DescriptionSelective histone deacetylase 1 (HDAC1) and histone deacetylase 2 (HDAC2) inhibitor
Molecular Target Histone deacetylase 1 (HDAC1) ; Histone deacetylase 2 (HDAC2)
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today